Follow
Kemal Yelekci
Title
Cited by
Cited by
Year
Drug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes
AD Elmezayen, A Al-Obaidi, AT Şahin, K Yelekçi
Journal of Biomolecular Structure and Dynamics 39 (8), 2980-2992, 2021
3942021
Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studies
G Bora-Tatar, D Dayangaç-Erden, AS Demir, S Dalkara, K Yelekçi, ...
Bioorganic & medicinal chemistry 17 (14), 5219-5228, 2009
2132009
New pyrazoline bearing 4 (3H)-quinazolinone inhibitors of monoamine oxidase: Synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity
N Gökhan-Kelekçi, S Koyunoğlu, S Yabanoğlu, K Yelekçi, Ö Özgen, ...
Bioorganic & medicinal chemistry 17 (2), 675-689, 2009
1862009
A computational study on the amine-oxidation mechanism of monoamine oxidase: Insight into the polar nucleophilic mechanism
SS Erdem, Ö Karahan, İ Yıldız, K Yelekçi
Organic & biomolecular chemistry 4 (4), 646-658, 2006
822006
Drug design for CNS diseases: polypharmacological profiling of compounds using cheminformatic, 3D-QSAR and virtual screening methodologies
K Nikolic, L Mavridis, T Djikic, J Vucicevic, D Agbaba, K Yelekci, ...
Frontiers in neuroscience 10, 198455, 2016
812016
Docking studies on monoamine oxidase-B inhibitors: Estimation of inhibition constants (Ki) of a series of experimentally tested compounds
M Toprakçí, K Yelekçi
Bioorganic & medicinal chemistry letters 15 (20), 4438-4446, 2005
702005
Synthesis of some novel hydrazone and 2-pyrazoline derivatives: Monoamine oxidase inhibitory activities and docking studies
B Evranos-Aksöz, S Yabanoğlu-Çiftçi, G Uçar, K Yelekçi, R Ertan
Bioorganic & medicinal chemistry letters 24 (15), 3278-3284, 2014
642014
Histone Deacetylase Inhibition Activity and Molecular Docking of (E )‐Resveratrol: Its Therapeutic Potential in Spinal Muscular Atrophy
D Dayangaç‐Erden, G Bora, P Ayhan, C Kocaefe, S Dalkara, K Yelekci, ...
Chemical biology & drug design 73 (3), 355-364, 2009
582009
Synthesis, molecular modeling, in vivo study, and anticancer activity of 1,2,4‐triazole containing hydrazide–hydrazones derived from (S)‐naproxen
Mİ Han, H Bekçi, AI Uba, Y Yıldırım, E Karasulu, A Cumaoğlu, ...
Archiv der Pharmazie 352 (6), 1800365, 2019
562019
Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors
N Gökhan-Kelekçi, ÖÖ Şimşek, A Ercan, K Yelekçi, ZS Şahin, Ş Işık, ...
Bioorganic & medicinal chemistry 17 (18), 6761-6772, 2009
482009
Electron spin resonance studies of monoamine oxidase B. First direct evidence for a substrate radical intermediate
K Yelekci, X Lu, RB Silverman
Journal of the American Chemical Society 111 (3), 1138-1140, 1989
431989
Observation of a flavin semiquinone in the resting state of monoamine oxidase B by electron paramagnetic resonance and electron nuclear double resonance spectroscopy
VJ DeRose, JCG Woo, WP Hawe, BM Hoffman, RB Silverman, K Yelekci
Biochemistry 35 (34), 11085-11091, 1996
401996
Identification of potential isoform-selective histone deacetylase inhibitors for cancer therapy: A combined approach of structure-based virtual screening, ADMET prediction and …
AI Uba, K Yelekçi
Journal of Biomolecular Structure and Dynamics 36 (12), 3231-3245, 2018
372018
cis‐cyclopropylamines as mechanism‐based inhibitors of monoamine oxidases
T Malcomson, K Yelekci, MT Borrello, A Ganesan, E Semina, N De Kimpe, ...
The FEBS Journal 282 (16), 3190-3198, 2015
362015
Docking of novel reversible monoamine oxidase-B inhibitors: efficient prediction of ligand binding sites and estimation of inhibitors thermodynamic properties
K Yelekci, Ö Karahan, M Toprakçı
Journal of neural transmission 114, 725-732, 2007
342007
Synthesis and screening of human monoamine oxidase‐A inhibitor effect of new 2‐pyrazoline and hydrazone derivatives
B Evranos‐Aksöz, İ Baysal, S Yabanoğlu‐Çiftçi, T Djikic, K Yelekçi, ...
Archiv der Pharmazie 348 (10), 743-756, 2015
332015
Flavonoids from Sideritis Species: Human Monoamine Oxidase (hMAO) Inhibitory Activities, Molecular Docking Studies and Crystal Structure of Xanthomicrol
FP Turkmenoglu, İ Baysal, S Ciftci-Yabanoglu, K Yelekci, H Temel, ...
Molecules 20 (5), 7454-7473, 2015
322015
Homology modeling of human histone deacetylase 10 and design of potential selective inhibitors
AI Uba, K Yelekçi
Journal of Biomolecular Structure and Dynamics, 2019
302019
New 2-pyrazoline and hydrazone derivatives as potent and selective monoamine oxidase A inhibitors
U Salgin-Goksen, G Telli, A Erikci, E Dedecengiz, BC Tel, FB Kaynak, ...
Journal of medicinal chemistry 64 (4), 1989-2009, 2021
282021
Synthesis, molecular docking and anticancer activity of diflunisal derivatives as cyclooxygenase enzyme inhibitors
GP Coşkun, T Djikic, TB Hayal, N Türkel, K Yelekçi, F Şahin, ...
Molecules 23 (8), 1969, 2018
272018
The system can't perform the operation now. Try again later.
Articles 1–20